Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator.

Fassbender K, Dempfle CE, Mielke O, Schwartz A, Daffertshofer M, Eschenfelder C, Dollman M, Hennerici M.

Stroke. 1999 Oct;30(10):2101-4.

2.

Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.

Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR; NINDS rtPA Stroke Study Group..

Stroke. 2006 Jul;37(7):1798-804. Epub 2006 Jun 8.

3.

Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.

Cocho D, Borrell M, Martí-Fàbregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvís R, Díaz-Manera JA, Martínez-Domeño A, Martínez-Lage M, Millán M, Fontcuberta J, Martí-Vilalta JL.

Stroke. 2006 Apr;37(4):996-9. Epub 2006 Feb 23.

4.

[Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].

Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.

J Cardiol. 1993;23(4):335-41. Japanese.

PMID:
8064582
5.
6.

Procoagulant effects of thrombolytic therapy in acute myocardial infarction.

Wang Y, Liu Q, Zhu J, Yuan Z, Ma X.

Chin Med Sci J. 2002 Mar;17(1):36-9.

PMID:
12894883
7.
8.

Changes in coagulation and fibrinolytic system after local intra-arterial thrombolysis for acute ischemic stroke.

Ueda T, Hatakeyama T, Sakaki S, Ohta S, Kumon Y, Uraoka T.

Neurol Med Chir (Tokyo). 1995 Mar;35(3):136-43.

9.

Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.

Gram J, Munkvad S, Leebeek FW, Kluft C, Jespersen J.

Coron Artery Dis. 1993 Apr;4(4):371-7.

PMID:
8261210
10.

Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.

Stehling F, Weber R, Ozcelik A, Bröcker M, Volbracht L, Diener HC, Busch E.

Neurosci Lett. 2008 Aug 15;441(1):39-43. doi: 10.1016/j.neulet.2008.05.102. Epub 2008 Jun 4.

PMID:
18597942
11.

[Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].

Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG.

Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3074-8. Chinese.

PMID:
18261355
12.

Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.

Mruk JS, Zoldhelyi P, Webster MW, Heras M, Grill DE, Holmes DR Jr, Fuster V, Chesebro JH.

Circulation. 1996 Feb 15;93(4):792-9.

PMID:
8641009
13.

Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.

Scharfstein JS, Abendschein DR, Eisenberg PR, George D, Cannon CP, Becker RC, Sobel B, Cupples LA, Braunwald E, Loscalzo J.

Am J Cardiol. 1996 Sep 1;78(5):503-10.

PMID:
8806332
14.

Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase.

Rowe AS, Greene CL, Snider CC, Carroll RC, Wiseman BF, Henry JM, Langdon JR, Craft RM.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1307-11. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.001. Epub 2014 Jan 16.

PMID:
24439128
15.

Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.

van Veen SQ, Levi M, van Vliet AK, Florquin S, van Gulik TM, Boermeester MA.

Crit Care Med. 2006 Nov;34(11):2799-805.

PMID:
17006359
16.
17.

Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.

Eisses MJ, Seidel K, Aldea GS, Chandler WL.

Anesth Analg. 2004 May;98(5):1208-16, table of contents.

PMID:
15105189
19.

Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.

Liu R, Liu Q, He S, Simpkins JW, Yang SH.

J Pharmacol Exp Ther. 2010 Mar;332(3):1006-12. doi: 10.1124/jpet.109.160937. Epub 2009 Dec 1.

20.

Posttrauma coagulation and fibrinolysis.

Gando S, Tedo I, Kubota M.

Crit Care Med. 1992 May;20(5):594-600.

PMID:
1533358

Supplemental Content

Support Center